Volume 14 Issue 2
Mar.  2023
Turn off MathJax
Article Contents
DONG Yaohua, SONG Hongmei. Neurological Manifestations in Familial Mediterranean Fever[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 334-338. doi: 10.12290/xhyxzz.2022-0093
Citation: DONG Yaohua, SONG Hongmei. Neurological Manifestations in Familial Mediterranean Fever[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 334-338. doi: 10.12290/xhyxzz.2022-0093

Neurological Manifestations in Familial Mediterranean Fever

doi: 10.12290/xhyxzz.2022-0093
Funds:

National Key Research and Development Program of China 2021YFC2702001

Beijing Natural Science Foundation L202050

More Information
  • Corresponding author: SONG Hongmei, E-mail: songhm1021@126.com
  • Received Date: 2022-03-01
  • Accepted Date: 2022-03-21
  • Available Online: 2022-10-06
  • Publish Date: 2023-03-30
  • Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations of the MEFV gene. The main clinical manifestations are recurrent fever and serous inflammation in various parts of the body. Some patients with FMF may also develop neurological manifestations such as epilepsy, demyelinating disease, aseptic meningitis. As neurological manifestations are rare in patients with FMF, the association between the two is often overlooked in clinical practice. In this paper, we reviewed the neurological manifestations of FMF and their relationship with genotypes, so as to deepen the understanding of the clinical manifestations of FMF and provide help for the diagnosis and treatment of patients with neurological manifestations.
  • loading
  • [1] Ozen S. Update in familial Mediterranean fever[J]. Curr Opin Rheumatol, 2021, 33: 398-402. doi:  10.1097/BOR.0000000000000821
    [2] Bhatt H, Cascella M. Familial Mediterranean Fever[M]. In StatPearls, StatPearls Publishing, 2022.
    [3] Shinar Y, Ceccherini I, Rowczenio D, et al. ISSAID/EMQN Best practice guidelines for the genetic diagnosis of Monognenic AIDs in the next generaion sequencing era[J]. Clin Chem, 2020, 66: 525-536. doi:  10.1093/clinchem/hvaa024
    [4] Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever[J]. Pediatr Neurol, 1993, 9: 301-302. doi:  10.1016/0887-8994(93)90068-N
    [5] Ertekin V, Selimoglu MA, Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey[J]. Pediatr Int, 2005, 47: 640-644. doi:  10.1111/j.1442-200x.2005.02140.x
    [6] Canpolat M, Gumus H, Gunduz Z, et al. Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey[J]. Neuropediatrics, 2017, 48: 79-85.
    [7] Canpolat M, Kumandas S, Poyrazoglu HG, et al. Preval-ence and risk factors of epilepsy among school children in Kayseri City Center, an urban area in Central Anatolia, Turkey[J]. Seizure, 2014, 23: 708-716. doi:  10.1016/j.seizure.2014.05.012
    [8] Salehzadeh F, Azami A, Motezarre M, et al. Neurological Manifestations in Familial Mediterranean Fever: a Genotype-Phenotype Correlation Study[J]. Open Access Rheumatol, 2020, 12: 15-19. doi:  10.2147/OARRR.S238649
    [9] World Health Organization. Epilepsy in the WHO Eastern Mediterranean region: bridging the gap[EB/OL].[2022-03-01]. https://apps.who.int/iris/handle/10665/119905.
    [10] Çomak E, Tüfekçi Ö, Kiliçbay F, et al. Febrile seizures in children with familial Mediterranean fever: Coincidence or association?[J]. Eur J Paediatr Neurol, 2015, 19: 572-576. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202117014.htm
    [11] Carman KB, Ekici A, Yimenicioglu S, et al. The preval-ence of febrile seizure and associated factors among Turkish children[J]. Int J Clin Pediatr, 2014, 3: 1-4.
    [12] Okan N, Okan M, Eralp O, et al. The prevalence of neurological disorders among children in Gemlik (Turkey)[J]. Dev Med Child Neurol, 1995, 37: 597-603.
    [13] Yakinci C, Kutlu NO, Durmaz Y, et al. Prevalence of febrile convulsion in 3637 children of primary school age in the province of Malatya[J]. Turk J Trop Pediatr, 2000, 46: 249-250. doi:  10.1093/tropej/46.4.249
    [14] Özen F, Kocak N, Kelekci S, et al. The prevalence of Familial Mediterranean Fever common gene mutations in patients with simple febrile seizures[J]. Eur Rev Med Pharmacol Sci, 2014, 18: 657-660.
    [15] Biro O, Gileles-Hillel A, Dor-Wollman T, et al. Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings[J]. Eur J Pediatr, 2022, 181: 973-978. doi:  10.1007/s00431-021-04286-7
    [16] Akman-Demir G, Gul A, Gurol E, et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?[J] J Neurol, 2006, 253: 928-934. doi:  10.1007/s00415-006-0137-8
    [17] Unal A, Dursun A, Emre U, et al. Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene?[J]. J Neurol Sci, 2010, 294: 38-42. doi:  10.1016/j.jns.2010.04.008
    [18] Shinar Y, Livneh A, Villa Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients[J]. Genes Immun, 2003, 4: 197-203. doi:  10.1038/sj.gene.6363967
    [19] Kalyoncu U, Eker A, Oguz KK, et al. Familial Mediterranean fever and central nervous system involvement: a case series[J]. Medicine, 2010, 89: 75-84. doi:  10.1097/MD.0b013e3181d5dca7
    [20] Yahalom G, Kivity S, Lidar M, et al. Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts[J]. Eur J Neurol, 2011, 18: 1146-1150. doi:  10.1111/j.1468-1331.2011.03356.x
    [21] Furlan R, Filippi M, Bergami A, et al. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study[J]. J Neurol Neurosurg Psychiatry, 1999, 67: 785-788. doi:  10.1136/jnnp.67.6.785
    [22] Elhani I, Dumont A, Vergneault H, et al. Association between familial Mediterranean fever and multiple sclerosis: A case series from the JIR cohort and systematic literature review[J]. Mult Scler Relat Disord, 2021, 50: 102834. doi:  10.1016/j.msard.2021.102834
    [23] Karachaliou I, Karachalios G, Charalabopoulos A, et al. Meningitis associated with familial Mediterranean fever[J]. Int J Clin Pract Suppl, 2005, 147: 60-61.
    [24] Schwabe AD, Monroe JB. Meningitis in familial Mediterranean fever[J]. Am J Med, 1988, 85: 715-717. doi:  10.1016/S0002-9343(88)80248-1
    [25] Barakat MH, Mustafa HT, Shakir RA. Mollaret's meningitis. A variant of recurrent hereditary polyserositis, both provoked by metaraminol[J]. Arch Neurol, 1988, 45: 926-927. doi:  10.1001/archneur.1988.00520320128030
    [26] Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF: published and own experience[J]. Best Pract Res Clin Rheumatol, 2012, 26: 119-133.
    [27] 李栋方, 唐文婷, 邱坤银, 等. 一个常染色体显性遗传型地中海热家系的临床及遗传学分析[J]. 中华医学遗传学杂志, 2021, 38: 719-722. doi:  10.3760/cma.j.cn511374-20200318-00175
    [28] Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension[J]. Neurology, 2002, 59: 1492.
    [29] Gökalp HZ, Başkaya MK, Aydin V. Pseudotumor cerebri with familial Mediterranean fever[J]. Clin Neurol Neurosurg, 1992, 94: 261-263. doi:  10.1016/0303-8467(92)90101-8
    [30] Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome[J]. J Neurol, 2017, 264: 1608-1616. doi:  10.1007/s00415-016-8377-8
    [31] Aksoy DY, Arici M, Kiykim AA, et al. Posterior leukoencephalopathy and nephrotic syndrome: just a coincidence?[J]. Am J Med Sci, 2004, 327: 156-159. doi:  10.1097/00000441-200403000-00008
    [32] Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasog-enic edema[J]. AJNR Am J Neuroradiol, 2008, 29: 1043-1049. doi:  10.3174/ajnr.A0929
    [33] Ulaşli AM, Kutlu G, Kocatürk Ö, et al. Posterior reversible encephalopathy during an attack of familial Mediterranean fever[J]. Rheumatol Int, 2012, 32: 1779-1781. doi:  10.1007/s00296-010-1388-3
    [34] Abbara S, Grateau G, Ducharme-Bénard S, et al. Association of Vasculitis and Familial Mediterranean Fever[J]. Front Immunol, 2019, 10: 763. doi:  10.3389/fimmu.2019.00763
    [35] Nussinovitch U, Volovitz B, Nussinovitch M, et al. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever[J]. Amyloid, 2011, 18: 206-210.
    [36] Lavi E, Maree A, Eisenstein EM, et al. Increased prevalence of attention-deficit hyperactivity disorder symptomato-logy in patients with familial Mediterranean fever[J]. Mod Rheumatol, 2022, 32: 422-426. doi:  10.1093/mr/roab009
    [37] Wilbur K, Makowsky M. Colchicine myotoxicity: case reports and literature review[J]. Pharmacotherapy, 2004, 24: 1784-1792. doi:  10.1592/phco.24.17.1784.52334
    [38] Ben-Chetrit E, Backenroth R. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene[J]. Ann Rheum Dis, 2001, 60: 146-149. doi:  10.1136/ard.60.2.146
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2208) PDF downloads(47) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return